Modulating the 3’ UTR region of MDM2 by ADAR1 can prevent the binding of miR-155, and enhance the reprogramming of progenitor cells into dormant leukemia stem cells.44 In some cases, A-to-I editing could also trigger abnormal splicing leading to drug resistance. Here, ADAR is linked to leukemia.